Trump seeks 20% tax on Mexican imports to build border wall

January 27, 2017

Washington, Jan 27: President Donald Trump is seeking to impose a 20 per cent tax on imports from countries which has a trade deficit with the US like Mexico in order to finance the construction of a border wall along its southern border, the White House said. This is one of the way to pay for the wall that the US is planning to construct along the US-Mexico border.

TrumptaxHowever the proposal is currently only for Mexico, White House Press Secretary Sean Spicer told reporters travelling with the Trump from Philadelphia to Washington DC abroad Air Force One. "When you look at the plan that's taking shape now, using comprehensive tax reform as a means to tax imports from countries that we have a trade deficit from, like Mexico," Spicer said.

"If you tax that USD 50 billion at 20 per cent of imports, which is by the way a practice that 160 other countries do -– right now, our country's policy is to tax exports and let imports flow freely in, which is ridiculous. By doing it that way we can do USD 10 billion a year and easily pay for the wall just through that mechanism alone," Spicer said.

"Right now we are focused on Mexico, but I think as we look comprehensively at our trade situation and countries that we have a deficit for, this is something the president has been talking about holistically," he said. "He has talked about a border tax. In particular companies that move out, ship things back in. But in this case, this really handles, is focused more on the immigration piece," Spicer said.

"Remember, keep in mind there are 160 other countries that do just this. We are one of the only major countries, in fact probably the only major country that doesn't treat imports this way," Spicer said. "In fact, we currently tax exports, not imports. This gets us in line frankly with the policies that the other countries around the world treat our products," he said.

"If you think about what a border tax on imports from countries like Mexico that we have a huge trade deficit does, that's really going to provide the funding," he added.

"But the other net positive that you have to realise is that through the wall, not only do we secure our border but I think we are going to save additional money that we would have had to spend on tracking down illegal immigrants and on immigration," Spicer said making a strong case for a physical barrier across the US-Mexico border.

Meanwhile, Spicer said the 20 per cent tax plan to be imposed on imports from countries with trade deficit like Mexico was in early stages and nothing has been finalised yet. The tax plan is in its "early stages," Spicer said. The President was really excited to see the level of support that both houses showed for his nominees, for his plan, for his desire to put America's security first," he said. Spicer said the President is still talking with the Republican leadership in the Congress.

"I don't think our job right now is to roll something out and or be prescriptive, it's to show that there are ways the wall can be paid for. Full stop," Spicer said in response to a question. "The idea was, there have been questions about how the President could pay for the wall. And the idea that, one idea through comprehensive tax reform is that there could be this idea that Speaker (Paul) Ryan and others have floated that through tax reform you could actually look at imports with countries that we have a trade deficit for, that can generate revenue," Spicer said.

"The idea is to show that generating revenue for the wall is not as difficult as some might have suggested. One measure alone could do this. So as we move forward the idea today wasn't rolling it out or being prescriptive or announce anything, it's to say hey look, it's not that hard to do," he said. Spicer said there is nothing to be rolled out yet.

"There's nothing to roll out so the idea of asking for details on something, we're not there yet. It could be a multitude of things," he said. "Instead of 20 per cent it could be 18, it could be five. But the idea is to say that for all the 'how could this ever happen,' it's to say 'okay, here's one idea that gets it done really easy. That's the idea, that there is a way that easily does this," Spicer said.

"You can do things in a very WTO-compliant way, but I'm not here to roll out a policy... Hypothetically yes, there are several things you can do and be compliant. You can say any country but if you look at just Mexico alone you can do that very easily," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 18,2020

Washington, Feb 18: The upcoming visit of President Donald Trump to India later this month has the potential to usher in a new era of bilateral ties between the two countries, a top American business advocacy group has said.

President Trump will pay a state visit to India on February 24 and 25 at the invitation of Prime Minister Narendra Modi. He would be accompanied by First Lady Melania Trump.

This would be the president's first bilateral visit in the third decade of the 21st century and also the first after his acquittal by the Senate in the impeachment trial.

"I believe President Trump's upcoming visit to India has the potential to usher in a new era of our bilateral ties," Mukesh Aghi, President of the US India Strategic and Partnership Forum (USISPF) said in a statement on Monday.

On the sidelines of the visit, the USISPF, in collaboration with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the ORF, has announced to organise a program entitled "US-India Forum: Partners for Growth".

The full-day discussion will focus on the key pillars defining India and the US' strategic, economic, and cultural partnership over the next decade.

"We have an opportunity before us to make real progress on multiple aspects of the relationship— whether it is upholding peace and security in the Indo-Pacific region; building upon an already strong energy partnership; developing co-production and co-development opportunities in the defense space; or strengthening bilateral trade," Aghi said.

"We look forward to an extremely successful visit and some concrete outcomes from the visit," he said.

The day-long programme on February 25 in New Delhi, will bring together over 500 senior business executives, members of the US-India think tank community and leading figures of the Indian diaspora to set the agenda for this strategic partnership.

Discussions during the day will touch upon areas, including the Indo-Pacific Strategy and Maritime Security; the US-India Defence Partnership, the US-India Energy Partnership, Elevating US-India Trade and Investment and Role of the Indian Diaspora in US-India Relations.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 11,2020

Geneva, Jul 11: The World Health Organization said Friday that it is still possible to bring coronavirus outbreaks under control, even though case numbers have more than doubled in the past six weeks.

WHO chief Tedros Adhanom Ghebreyesus said the examples of Italy, Spain, South Korea and India's biggest slum showed that however bad a outbreak was, the virus could still be reined in through aggressive action.

"In the last six weeks cases have more than doubled," Tedros told a virtual press conference in Geneva.

However, "there are many examples from around the world that have shown that even if the outbreak is very intense, it can still be brought back under control," said Tedros.

"And some of these examples are Italy, Spain and South Korea, and even in Dharavi -- a densely packed area in the megacity of Mumbai -- a strong focus on community engagement and the basics of testing, tracing, isolating and treating all those that are sick is key to breaking the chains of transmission and suppressing the virus."

The novel coronavirus has killed at least 555,000 people worldwide since the outbreak emerged in China last December, according to a tally from official sources compiled by AFP on Friday.

Nearly 12.3 million cases have been registered in 196 countries and territories.

"Across all walks of life, we are all being tested to the limit," Tedros said, "from countries where there is exponential growth, to places that are loosening restrictions and now starting to see cases rise.

"Only aggressive action combined with national unity and global solidarity can turn this pandemic around."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.